Biosimilars: Can They Break Through?
18 November 2015
Washington, D.C.
Past Event
Location
Washington, D.C.
Agenda
8:00 a.m. Eastern
Partner David Rosen is a featured speaker for POLITICO’s Pro Health Care Report taking place on November 18, 2015, in Washington D.C.
The report, presented by the Alliance for Patient Access (AfPA) and titled “Biosimilars: Can They Break Through?” will include discussion on the policy issues surrounding biosimilars in the United States. Topics will include:
- Given pending FDA regulations, what are the obstacles in getting biosimilars to market?
- What are the concerns surrounding the labeling or prescriber information, and why is the issue of naming so hotly contested?
People
Related Services
Sectors
Insights
Federal Advisory Committee on Insurance (“FACI”) June Meeting: FIO to Continue Focus on Macroprudential Issues
02 June 2023
Legal News: Insurance
Remote Work Considerations In A Post-Pandemic World
01 June 2023
Law360
Supreme Court Overturns FCA Scienter Cases
01 June 2023
Foley Earns Top Rankings in Chambers USA 2023
01 June 2023
Bryan House and Eric Pearson Author Article on Important Case for Wisconsin CPAs
30 May 2023
On Balance Magazine
Ai4 2023
8 August 2023
Las Vegas, NV
How Current Challenges Will Change the Business of Health Care
27 June 2023
San Francisco, CA
AI in HR: Understanding the Impact, Opportunities, and Avoiding Pitfalls
21 June 2023
Webinar
June 2023 Midwest Cyber Security Alliance Meeting | Cybersecurity and Insurance Trends: Stay on Top to Finish 2023 Strong
15 June 2023
Milwaukee, WI / Webinar
Biosimilars: Can They Break Through?
Location
Washington, D.C.
Agenda
8:00 a.m. Eastern